Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
Abstract Neutral antagonists of GPCRs remain relatively rare-indeed, a large majority of GPCR antagonists are actually inverse agonists. The synthetic cannabinoid receptor agonist (SCRA) EG‐018 was recently reported as a low efficacy cannabinoid receptor agonist. Here we report a comparative charact...
Saved in:
Main Authors: | David B. Finlay (Author), Thuy Nguyen (Author), Thomas F. Gamage (Author), Shuli Chen (Author), Daniel G. Barrus (Author), Purvi R. Patel (Author), Brian F. Thomas (Author), Jenny L. Wiley (Author), Yanan Zhang (Author), Michelle Glass (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
by: Monica Patel, et al.
Published: (2023) -
Synthetic Cannabinoid Receptor Agonist 'JWH-018' does not mimic Serotonin
by: Adam Pottsa, et al.
Published: (2022) -
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019) -
Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5
by: Yaliang Tang, et al.
Published: (2021) -
Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
by: Zachary W. Reichenbach, et al.
Published: (2022)